Discovering the Benefits and Short Falls of Using IPS-derived RPE Cells
Time: 1:00 pm
day: Preclinical PM
Details:
IPS-derived RPE cells present as an exciting preclinical model to advance the preclinical testing for dry AMD, however there are still challenges to overcome. Join the discussion by:
- Strategizing how to replicate the many cell types that contribute to dry AMD in an IPS RPE model
- Understanding how well the IPS RPE models replicate what is happening in vivo
- Navigating the limitations of the IPS RPE models lacking a photoreceptor and exploring if co-culturing could overcome this limitation
- Delving into the importance of growing the IPS-derived RPE cells under stressful conditions to mimic the conditions of the disease • Exploring the scalability capacity of iPS-derived RPE cells
- Exploring the scalability capacity of iPS-derived RPE cells
